Predict your next investment

Venture Capital
oceanpine.net

See what CB Insights has to offer

Investments

39

Portfolio Exits

2

Funds

2

About Oceanpine Capital

Oceanpine Capital is a professional investment management firm dedicated to long-term investment with a focus on value creation. The firm provides long-term capital and professional value-added services to high-growth enterprises and start-up companies, with a focus on investment opportunities in the TMT, consumption upgrade, advanced manufacturing, and healthcare sectors. It mainly invests in private companies with rapid growth, but also looks at some opportunities in public companies. Oceanpine Capital also operates Oceanpine Healthcare Fund (海松医疗基金), a healthcare venture fund that aims to connect innovation in the US to the Chinese consumer base and primarily invests in Chinese and US firms with core technologies and proprietary R&D capabilities.

Oceanpine Capital Headquarter Location

19F Tower H, Phoenix Place A5 ShuGuangXiLi, Chaoyang District

Beijing, Beijing, 100028,

China

+86 10 6195 9000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Oceanpine Capital News

DealShot: 14 Deals Worth $95 Million With Eight Roads, Oceanpine Capital Among Others

Aug 5, 2021

China Money Network’s DealShot provides detailed information on venture capital and private equity deals in China on a daily basis. Here you can find out where Chinese investors have been investing their money each workday. DealShot: 14 Deals Worth $95 Million With Eight Roads, Oceanpine Capital Among Others comes from China Money Network: Primary Data for China’s Primary Markets!…

Oceanpine Capital Investments

39 Investments

Oceanpine Capital has made 39 investments. Their latest investment was in MingMed Biotech as part of their Series A - II on September 9, 2021.

CBI Logo

Oceanpine Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/13/2021

Series A - II

MingMed Biotech

$50M

Yes

7

8/4/2021

Series B

Imperial Vision

$15.46M

Yes

2

7/30/2021

Series B

SVOLT Energy

$1,580M

Yes

10

7/12/2021

Series C

Subscribe to see more

$99M

Subscribe to see more

10

6/24/2021

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/13/2021

8/4/2021

7/30/2021

7/12/2021

6/24/2021

Round

Series A - II

Series B

Series B

Series C

Seed VC - II

Company

MingMed Biotech

Imperial Vision

SVOLT Energy

Subscribe to see more

Subscribe to see more

Amount

$50M

$15.46M

$1,580M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

7

2

10

10

10

Oceanpine Capital Portfolio Exits

2 Portfolio Exits

Oceanpine Capital has 2 portfolio exits. Their latest portfolio exit was Energy Monster on April 01, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/1/2021

IPO

$991

2

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

4/1/2021

00/00/0000

Exit

IPO

Subscribe to see more

Companies

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Sources

2

10

Oceanpine Capital Fund History

2 Fund Histories

Oceanpine Capital has 2 funds, including Oceanpine Capital Fund II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/30/2020

Oceanpine Capital Fund II

$400M

2

Nanjing Jiangbei Xinqu Medical Innovation Industry Fund

Subscribe to see more

$99M

10

Closing Date

12/30/2020

Fund

Oceanpine Capital Fund II

Nanjing Jiangbei Xinqu Medical Innovation Industry Fund

Fund Type

Subscribe to see more

Status

Amount

$400M

$99M

Sources

2

10

Oceanpine Capital Team

3 Team Members

Oceanpine Capital has 3 team members, including current Chief Executive Officer, Dave Chenn.

Name

Work History

Title

Status

Dave Chenn

Chief Executive Officer

Current

Liguang Chen

Founding Partner

Current

Jigang Sun

Founding Partner

Current

Name

Dave Chenn

Liguang Chen

Jigang Sun

Work History

Title

Chief Executive Officer

Founding Partner

Founding Partner

Status

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.